世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Autoimmune Disorders Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0523
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ブリッジ療法、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、寄生虫療法、活性化誘導アッセイ、飛行時間型質量分析サイトメトリー）、用途別市場規模（全身性自己免疫疾患、限局性自己免疫疾患）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・自己免疫疾患治療の市場動向
・企業の競争状況、市場シェア
・自己免疫疾患治療の種類別市場規模（ブリッジ療法、組換え技術、糞便細菌療法、造血幹細胞移植、光線療法、寄生虫療法、活性化誘導アッセイ、飛行時間型質量分析サイトメトリー）
・自己免疫疾患治療の用途別市場規模（全身性自己免疫疾患、限局性自己免疫疾患）
・自己免疫疾患治療の北米市場規模2016-2027（アメリカ、カナダ）
・自己免疫疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・自己免疫疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・自己免疫疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・自己免疫疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott Laboratories、Roche Diagnostics、Siemens Healthcare、Johnson & Johnson、Boehringer Ingelheim、GlaxoSmithKline、AstraZeneca、Sanofi、Merck、Pfizer）
・結論

Graves’ disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in women than in men, which results from the influence of estrogen on immune system.

Market Analysis and Insights: Global Autoimmune Disorders Treatment Market
The global Autoimmune Disorders Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Disorders Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Disorders Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Disorders Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Disorders Treatment market.

Global Autoimmune Disorders Treatment Scope and Market Size
Autoimmune Disorders Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bridge therapy
Recombinant technology
Fecal bacteriotherapy
Hematopoietic stem-cell transplantation
Phototherapy
Helminthic therapy
Activation-induced assays
Cytometry by time-of-flight mass spectrometry

Segment by Application
Systemic autoimmune diseases
Localized autoimmune diseases

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Roche Diagnostics
Siemens Healthcare
Johnson & Johnson
Boehringer Ingelheim
GlaxoSmithKline
AstraZeneca
Sanofi
Merck

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disorders Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bridge therapy
1.2.3 Recombinant technology
1.2.4 Fecal bacteriotherapy
1.2.5 Hematopoietic stem-cell transplantation
1.2.6 Phototherapy
1.2.7 Helminthic therapy
1.2.8 Activation-induced assays
1.2.9 Cytometry by time-of-flight mass spectrometry
1.3 Market by Application
1.3.1 Global Autoimmune Disorders Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Systemic autoimmune diseases
1.3.3 Localized autoimmune diseases
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Autoimmune Disorders Treatment Market Perspective (2016-2027)
2.2 Autoimmune Disorders Treatment Growth Trends by Regions
2.2.1 Autoimmune Disorders Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autoimmune Disorders Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Autoimmune Disorders Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Autoimmune Disorders Treatment Industry Dynamic
2.3.1 Autoimmune Disorders Treatment Market Trends
2.3.2 Autoimmune Disorders Treatment Market Drivers
2.3.3 Autoimmune Disorders Treatment Market Challenges
2.3.4 Autoimmune Disorders Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disorders Treatment Players by Revenue
3.1.1 Global Top Autoimmune Disorders Treatment Players by Revenue (2016-2021)
3.1.2 Global Autoimmune Disorders Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Autoimmune Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disorders Treatment Revenue
3.4 Global Autoimmune Disorders Treatment Market Concentration Ratio
3.4.1 Global Autoimmune Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disorders Treatment Revenue in 2020
3.5 Autoimmune Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Autoimmune Disorders Treatment Product Solution and Service
3.7 Date of Enter into Autoimmune Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Autoimmune Disorders Treatment Breakdown Data by Type
4.1 Global Autoimmune Disorders Treatment Historic Market Size by Type (2016-2021)
4.2 Global Autoimmune Disorders Treatment Forecasted Market Size by Type (2022-2027)

5 Autoimmune Disorders Treatment Breakdown Data by Application
5.1 Global Autoimmune Disorders Treatment Historic Market Size by Application (2016-2021)
5.2 Global Autoimmune Disorders Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Autoimmune Disorders Treatment Market Size (2016-2027)
6.2 North America Autoimmune Disorders Treatment Market Size by Type
6.2.1 North America Autoimmune Disorders Treatment Market Size by Type (2016-2021)
6.2.2 North America Autoimmune Disorders Treatment Market Size by Type (2022-2027)
6.2.3 North America Autoimmune Disorders Treatment Market Size by Type (2016-2027)
6.3 North America Autoimmune Disorders Treatment Market Size by Application
6.3.1 North America Autoimmune Disorders Treatment Market Size by Application (2016-2021)
6.3.2 North America Autoimmune Disorders Treatment Market Size by Application (2022-2027)
6.3.3 North America Autoimmune Disorders Treatment Market Size by Application (2016-2027)
6.4 North America Autoimmune Disorders Treatment Market Size by Country
6.4.1 North America Autoimmune Disorders Treatment Market Size by Country (2016-2021)
6.4.2 North America Autoimmune Disorders Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Autoimmune Disorders Treatment Market Size (2016-2027)
7.2 Europe Autoimmune Disorders Treatment Market Size by Type
7.2.1 Europe Autoimmune Disorders Treatment Market Size by Type (2016-2021)
7.2.2 Europe Autoimmune Disorders Treatment Market Size by Type (2022-2027)
7.2.3 Europe Autoimmune Disorders Treatment Market Size by Type (2016-2027)
7.3 Europe Autoimmune Disorders Treatment Market Size by Application
7.3.1 Europe Autoimmune Disorders Treatment Market Size by Application (2016-2021)
7.3.2 Europe Autoimmune Disorders Treatment Market Size by Application (2022-2027)
7.3.3 Europe Autoimmune Disorders Treatment Market Size by Application (2016-2027)
7.4 Europe Autoimmune Disorders Treatment Market Size by Country
7.4.1 Europe Autoimmune Disorders Treatment Market Size by Country (2016-2021)
7.4.2 Europe Autoimmune Disorders Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disorders Treatment Market Size (2016-2027)
8.2 Asia-Pacific Autoimmune Disorders Treatment Market Size by Type
8.2.1 Asia-Pacific Autoimmune Disorders Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autoimmune Disorders Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autoimmune Disorders Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Autoimmune Disorders Treatment Market Size by Application
8.3.1 Asia-Pacific Autoimmune Disorders Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autoimmune Disorders Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autoimmune Disorders Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Autoimmune Disorders Treatment Market Size by Region
8.4.1 Asia-Pacific Autoimmune Disorders Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autoimmune Disorders Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Autoimmune Disorders Treatment Market Size (2016-2027)
9.2 Latin America Autoimmune Disorders Treatment Market Size by Type
9.2.1 Latin America Autoimmune Disorders Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Autoimmune Disorders Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Autoimmune Disorders Treatment Market Size by Type (2016-2027)
9.3 Latin America Autoimmune Disorders Treatment Market Size by Application
9.3.1 Latin America Autoimmune Disorders Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Autoimmune Disorders Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Autoimmune Disorders Treatment Market Size by Application (2016-2027)
9.4 Latin America Autoimmune Disorders Treatment Market Size by Country
9.4.1 Latin America Autoimmune Disorders Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Autoimmune Disorders Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disorders Treatment Market Size (2016-2027)
10.2 Middle East & Africa Autoimmune Disorders Treatment Market Size by Type
10.2.1 Middle East & Africa Autoimmune Disorders Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autoimmune Disorders Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autoimmune Disorders Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Autoimmune Disorders Treatment Market Size by Application
10.3.1 Middle East & Africa Autoimmune Disorders Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autoimmune Disorders Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autoimmune Disorders Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Autoimmune Disorders Treatment Market Size by Country
10.4.1 Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disorders Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disorders Treatment Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Details
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Autoimmune Disorders Treatment Introduction
11.2.4 Roche Diagnostics Revenue in Autoimmune Disorders Treatment Business (2016-2021)
11.2.5 Roche Diagnostics Recent Development
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Details
11.3.2 Siemens Healthcare Business Overview
11.3.3 Siemens Healthcare Autoimmune Disorders Treatment Introduction
11.3.4 Siemens Healthcare Revenue in Autoimmune Disorders Treatment Business (2016-2021)
11.3.5 Siemens Healthcare Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Autoimmune Disorders Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Autoimmune Disorders Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Autoimmune Disorders Treatment Introduction
11.5.4 Boehringer Ingelheim Revenue in Autoimmune Disorders Treatment Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Autoimmune Disorders Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Autoimmune Disorders Treatment Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Autoimmune Disorders Treatment Introduction
11.7.4 AstraZeneca Revenue in Autoimmune Disorders Treatment Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Autoimmune Disorders Treatment Introduction
11.8.4 Sanofi Revenue in Autoimmune Disorders Treatment Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Autoimmune Disorders Treatment Introduction
11.9.4 Merck Revenue in Autoimmune Disorders Treatment Business (2016-2021)
11.9.5 Merck Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Autoimmune Disorders Treatment Introduction
11.10.4 Pfizer Revenue in Autoimmune Disorders Treatment Business (2016-2021)
11.10.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Autoimmune Disorders Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bridge therapy
Table 3. Key Players of Recombinant technology
Table 4. Key Players of Fecal bacteriotherapy
Table 5. Key Players of Hematopoietic stem-cell transplantation
Table 6. Key Players of Phototherapy
Table 7. Key Players of Helminthic therapy
Table 8. Key Players of Activation-induced assays
Table 9. Key Players of Cytometry by time-of-flight mass spectrometry
Table 10. Global Autoimmune Disorders Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Autoimmune Disorders Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Autoimmune Disorders Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Autoimmune Disorders Treatment Market Share by Regions (2016-2021)
Table 14. Global Autoimmune Disorders Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Autoimmune Disorders Treatment Market Share by Regions (2022-2027)
Table 16. Autoimmune Disorders Treatment Market Trends
Table 17. Autoimmune Disorders Treatment Market Drivers
Table 18. Autoimmune Disorders Treatment Market Challenges
Table 19. Autoimmune Disorders Treatment Market Restraints
Table 20. Global Autoimmune Disorders Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Autoimmune Disorders Treatment Market Share by Players (2016-2021)
Table 22. Global Top Autoimmune Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disorders Treatment as of 2020)
Table 23. Ranking of Global Top Autoimmune Disorders Treatment Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Autoimmune Disorders Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Autoimmune Disorders Treatment Product Solution and Service
Table 27. Date of Enter into Autoimmune Disorders Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Autoimmune Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Autoimmune Disorders Treatment Revenue Market Share by Type (2016-2021)
Table 31. Global Autoimmune Disorders Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Autoimmune Disorders Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Autoimmune Disorders Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Autoimmune Disorders Treatment Revenue Market Share by Application (2016-2021)
Table 35. Global Autoimmune Disorders Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Autoimmune Disorders Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Autoimmune Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Autoimmune Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Autoimmune Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Autoimmune Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Autoimmune Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Autoimmune Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Autoimmune Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Autoimmune Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Autoimmune Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Autoimmune Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Autoimmune Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Autoimmune Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Autoimmune Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Autoimmune Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Autoimmune Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Autoimmune Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Autoimmune Disorders Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Autoimmune Disorders Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Autoimmune Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Autoimmune Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Autoimmune Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Autoimmune Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Autoimmune Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Autoimmune Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Autoimmune Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Autoimmune Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Autoimmune Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Autoimmune Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 67. Abbott Laboratories Company Details
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Autoimmune Disorders Treatment Product
Table 70. Abbott Laboratories Revenue in Autoimmune Disorders Treatment Business (2016-2021) & (US$ Million)
Table 71. Abbott Laboratories Recent Development
Table 72. Roche Diagnostics Company Details
Table 73. Roche Diagnostics Business Overview
Table 74. Roche Diagnostics Autoimmune Disorders Treatment Product
Table 75. Roche Diagnostics Revenue in Autoimmune Disorders Treatment Business (2016-2021) & (US$ Million)
Table 76. Roche Diagnostics Recent Development
Table 77. Siemens Healthcare Company Details
Table 78. Siemens Healthcare Business Overview
Table 79. Siemens Healthcare Autoimmune Disorders Treatment Product
Table 80. Siemens Healthcare Revenue in Autoimmune Disorders Treatment Business (2016-2021) & (US$ Million)
Table 81. Siemens Healthcare Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Autoimmune Disorders Treatment Product
Table 85. Johnson & Johnson Revenue in Autoimmune Disorders Treatment Business (2016-2021) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Autoimmune Disorders Treatment Product
Table 90. Boehringer Ingelheim Revenue in Autoimmune Disorders Treatment Business (2016-2021) & (US$ Million)
Table 91. Boehringer Ingelheim Recent Development
Table 92. GlaxoSmithKline Company Details
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Autoimmune Disorders Treatment Product
Table 95. GlaxoSmithKline Revenue in Autoimmune Disorders Treatment Business (2016-2021) & (US$ Million)
Table 96. GlaxoSmithKline Recent Development
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Autoimmune Disorders Treatment Product
Table 100. AstraZeneca Revenue in Autoimmune Disorders Treatment Business (2016-2021) & (US$ Million)
Table 101. AstraZeneca Recent Development
Table 102. Sanofi Company Details
Table 103. Sanofi Business Overview
Table 104. Sanofi Revenue in Autoimmune Disorders Treatment Business (2016-2021) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Merck Company Details
Table 107. Merck Business Overview
Table 108. Merck Autoimmune Disorders Treatment Product
Table 109. Merck Revenue in Autoimmune Disorders Treatment Business (2016-2021) & (US$ Million)
Table 110. Merck Recent Development
Table 111. Pfizer Company Details
Table 112. Pfizer Business Overview
Table 113. Pfizer Autoimmune Disorders Treatment Product
Table 114. Pfizer Revenue in Autoimmune Disorders Treatment Business (2016-2021) & (US$ Million)
Table 115. Pfizer Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disorders Treatment Market Share by Type: 2020 VS 2027
Figure 2. Bridge therapy Features
Figure 3. Recombinant technology Features
Figure 4. Fecal bacteriotherapy Features
Figure 5. Hematopoietic stem-cell transplantation Features
Figure 6. Phototherapy Features
Figure 7. Helminthic therapy Features
Figure 8. Activation-induced assays Features
Figure 9. Cytometry by time-of-flight mass spectrometry Features
Figure 10. Global Autoimmune Disorders Treatment Market Share by Application: 2020 VS 2027
Figure 11. Systemic autoimmune diseases Case Studies
Figure 12. Localized autoimmune diseases Case Studies
Figure 13. Autoimmune Disorders Treatment Report Years Considered
Figure 14. Global Autoimmune Disorders Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Autoimmune Disorders Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Autoimmune Disorders Treatment Market Share by Regions: 2020 VS 2027
Figure 17. Global Autoimmune Disorders Treatment Market Share by Regions (2022-2027)
Figure 18. Global Autoimmune Disorders Treatment Market Share by Players in 2020
Figure 19. Global Top Autoimmune Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disorders Treatment as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Autoimmune Disorders Treatment Revenue in 2020
Figure 21. Global Autoimmune Disorders Treatment Revenue Market Share by Type (2016-2021)
Figure 22. Global Autoimmune Disorders Treatment Revenue Market Share by Type (2022-2027)
Figure 23. North America Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Autoimmune Disorders Treatment Market Share by Type (2016-2027)
Figure 25. North America Autoimmune Disorders Treatment Market Share by Application (2016-2027)
Figure 26. North America Autoimmune Disorders Treatment Market Share by Country (2016-2027)
Figure 27. United States Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Autoimmune Disorders Treatment Market Share by Type (2016-2027)
Figure 31. Europe Autoimmune Disorders Treatment Market Share by Application (2016-2027)
Figure 32. Europe Autoimmune Disorders Treatment Market Share by Country (2016-2027)
Figure 33. Germany Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Autoimmune Disorders Treatment Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Autoimmune Disorders Treatment Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Autoimmune Disorders Treatment Market Share by Region (2016-2027)
Figure 43. China Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Autoimmune Disorders Treatment Market Share by Type (2016-2027)
Figure 51. Latin America Autoimmune Disorders Treatment Market Share by Application (2016-2027)
Figure 52. Latin America Autoimmune Disorders Treatment Market Share by Country (2016-2027)
Figure 53. Mexico Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Autoimmune Disorders Treatment Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Autoimmune Disorders Treatment Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Autoimmune Disorders Treatment Market Share by Country (2016-2027)
Figure 59. Turkey Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Autoimmune Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abbott Laboratories Revenue Growth Rate in Autoimmune Disorders Treatment Business (2016-2021)
Figure 63. Roche Diagnostics Revenue Growth Rate in Autoimmune Disorders Treatment Business (2016-2021)
Figure 64. Siemens Healthcare Revenue Growth Rate in Autoimmune Disorders Treatment Business (2016-2021)
Figure 65. Johnson & Johnson Revenue Growth Rate in Autoimmune Disorders Treatment Business (2016-2021)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Autoimmune Disorders Treatment Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Autoimmune Disorders Treatment Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Autoimmune Disorders Treatment Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Autoimmune Disorders Treatment Business (2016-2021)
Figure 70. Merck Revenue Growth Rate in Autoimmune Disorders Treatment Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Autoimmune Disorders Treatment Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Diseases Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0522 2021年4月 98Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（輸血、サプリメント、医薬品、理学療法、その他）、用途別市場規模（病院、医療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0521 2021年4月 125Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤）、用途別市場規模（病院、クリニック、ドラッグストア、その他）...

世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disease Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0520 2021年4月 93Pages
QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤、その他）、用途別市場規模（病院、クリニック、独立型薬局、その...

世界の筋骨格系障害治療市場規模・現状・予測（2021年-2027年）

Global Musculoskeletal Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3975 2021年4月 97Pages
QYResearch社発行の本調査資料では、筋骨格系障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東...

世界の神経精神障害＆治療市場規模・現状・予測（2021年-2027年）

Global Neuropsychiatric Disorders and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4097 2021年4月 97Pages
QYResearch社発行の本調査資料では、神経精神障害＆治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、ショック治療、その他）、用途別市場規模（病院、診療所、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の双極性障害治療市場規模・現状・予測（2021年-2027年）

Global Bipolar Disorders and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0855 2021年4月 95Pages
QYResearch社発行の本調査資料では、双極性障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の骨・ミネラル代謝異常治療市場規模・現状・予測（2021年-2027年）

Global Bone and Mineral Metabolism Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0938 2021年4月 91Pages
QYResearch社発行の本調査資料では、骨・ミネラル代謝異常治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビスホスホネート、エストロゲン、リン吸着剤、非カルシウム、非金属ベースバインダー、金属ベースバインダー、マグネシウムベースバイン...

世界の甲状腺障害治療市場規模・現状・予測（2021年-2027年）

Global Thyroid Gland Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5653 2021年4月 98Pages
QYResearch社発行の本調査資料では、甲状腺障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（甲状腺機能低下症、甲状腺機能亢進症）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の視神経障害治療市場規模・現状・予測（2021年-2027年）

Global Optic Nerve Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4284 2021年4月 95Pages
QYResearch社発行の本調査資料では、視神経障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医療、手術治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド...

世界の代謝障害治療市場規模・現状・予測（2021年-2027年）

Global Metabolic Disorders Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3715 2021年4月 97Pages
QYResearch社発行の本調査資料では、代謝障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝治療薬、その他）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、ア...

世界の造血幹細胞移植（HSCT）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hematopoietic Stem Cell Transplantation (HSCT) Market The global Hematopoietic Stem Cell Transplantation (HSCT) market size is projected to reach US$ 24 million by 2026, from US$ 15 million in 2019, at a CAGR of 7.3% during 2021-2026. With industry-standard accur…
世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autoimmune Diseases Treatment Market The global Autoimmune Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
世界の造血幹細胞移植（HSCT）市場 2021：企業別、地域別、種類・用途別 The Hematopoietic Stem Cell Transplantation (HSCT) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年） Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors. Market Analysis and Insights: Global Autoimmune Disease Treatment Market The glob…
世界の変形性関節症幹細胞治療市場規模・現状・予測（2021年-2027年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…